Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia

Talha Badar, Damian R. Handisides, Juliana M. Benito, Mary Ann Richie, Gautam Borthakur, Elias Jabbour, Karine Harutyunyan, Sergej Konoplev, Stefan Faderl, Stew Kroll, Michael Andreeff, Tillman Pearce, Hagop M. Kantarjian, Jorge E. Cortes, Deborah A. Thomas, Marina Konopleva

Research output: Contribution to journal › Article › peer-review